Skip to main content
CDC Website

STD/STI

Pelvic Inflammatory Disease (PID) – CDC Basic Fact Sheet

This fact sheet answers basic questions about pelvic inflammatory disease; including what causes PID, how to reduce the risk of development, and recommendations for prevention. 

Gonorrhea – CDC Basic Fact Sheet

This fact sheet answers general questions about Gonorrhea; including how gonorrhea is spread, how to reduce the risk of getting chlamydia, and treatment options.

Chlamydia – CDC Basic Fact Sheet

This fact sheet answers general questions about chlamydia; including how chlamydia is spread, how to reduce the risk of getting chlamydia, and treatment options.

NIH Herpes Simplex Strategic Plan 2023

This plan outlines the HSV research framework with four strategic priorities: improving fundamental knowledge of HSV biology, pathogenesis, and epidemiology; accelerating research to improve HSV diagnosis; improving strategies to treat HSV while seeking a curative therapeutic; and, advancing research to prevent HSV infection.

Resources on Minor Consent for STI Services

This resource is geared towards local, state, and national organizations and agencies to strengthen their support for minor consent and includes talking points demonstrating the need for and benefit of the ability for minors to consent for STI testing.

Congenital Syphilis Media Campaigns

This resources includes Syphilis media campaign materials, findings from focus groups, and program evaluation outcomes of campaigns that other jurisdictions have previously developed.

STI Testing: New Point-of-Care Advances

A webinar on a new point-of-care technology for testing sexually transmitted infections and the impact of its use for health departments

Managing The Current Bicillin L-A Shortage: One-Time Transfer of Medications HRSA Notification

This guideline discusses how as STI programs around the country navigate the ongoing shortage of Bicillin L-A, public health and STI programs may need to move Bicillin L-A from one 340B covered entity to another 340B covered entity. This memo provides instructions on how to move 340B Bicillin L-A in order to provide timely treatment to patients.